Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sinto

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos One|March 7, 2024
Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral HospitalRobert Sinto, Khie Chen Lie, Siti Setiati, et al.
F1000Research|February 11, 2025
Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trialMurdani Abdullah, Jeanne Adiwinata Pawitan, Cosphiadi Irawan, et al.
Vaccines|April 27, 2024
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac<sup>®</sup> and ChAdOx1-S Vaccines for SARS-CoV-2Nina Dwi Putri, Aqila Sakina Zhafira, Pratama Wicaksana, et al.
BMC Infectious Diseases|August 1, 2024
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workersSuwarti Suwarti, Gilbert Lazarus, Sabighoh Zanjabila, et al.
International Journal of STD & AIDS|August 20, 2024
Mortality of cytomegalovirus infection among people living with HIV: A retrospective study from a tertiary hospital in IndonesiaEvy Yunihastuti, Nia Kurniati, Muhammad Yusuf, et al.
Vaccines|April 23, 2025
Epidemiology and Clinical Features of Mpox in Jakarta, Indonesia, August 2022-December 2023Hanny Nilasari, Eliza Miranda, Melani Marissa, et al.
Nature Communications|September 29, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trialJohn D Hart, Eddy Fadlyana, Nadia Mazarakis, et al.
The Lancet Regional Health. Southeast Asia|March 14, 2024
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort studyAnis Karuniawati, Ayodhia Pitaloka Pasaribu, Gilbert Lazarus, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
BMJ Global Health|October 21, 2025
Factors associated with positive blood cultures in children in nine African and Asian countries: the ACORN2 surveillance networkCristina Ardura-Garcia, Jill Hopkins, Sue J Lee, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos One|March 7, 2024
Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral HospitalRobert Sinto, Khie Chen Lie, Siti Setiati, et al.
F1000Research|February 11, 2025
Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trialMurdani Abdullah, Jeanne Adiwinata Pawitan, Cosphiadi Irawan, et al.
Vaccines|April 27, 2024
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac<sup>®</sup> and ChAdOx1-S Vaccines for SARS-CoV-2Nina Dwi Putri, Aqila Sakina Zhafira, Pratama Wicaksana, et al.
BMC Infectious Diseases|August 1, 2024
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workersSuwarti Suwarti, Gilbert Lazarus, Sabighoh Zanjabila, et al.
International Journal of STD & AIDS|August 20, 2024
Mortality of cytomegalovirus infection among people living with HIV: A retrospective study from a tertiary hospital in IndonesiaEvy Yunihastuti, Nia Kurniati, Muhammad Yusuf, et al.
Vaccines|April 23, 2025
Epidemiology and Clinical Features of Mpox in Jakarta, Indonesia, August 2022-December 2023Hanny Nilasari, Eliza Miranda, Melani Marissa, et al.
Nature Communications|September 29, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trialJohn D Hart, Eddy Fadlyana, Nadia Mazarakis, et al.
The Lancet Regional Health. Southeast Asia|March 14, 2024
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort studyAnis Karuniawati, Ayodhia Pitaloka Pasaribu, Gilbert Lazarus, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
BMJ Global Health|October 21, 2025
Factors associated with positive blood cultures in children in nine African and Asian countries: the ACORN2 surveillance networkCristina Ardura-Garcia, Jill Hopkins, Sue J Lee, et al.
Pageof 6